Literature DB >> 18583063

Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein/presenilin 1 transgenic mice.

M Popović1, M Caballero-Bleda, I Kadish, T Van Groen.   

Abstract

The depletion of neuronal calcium binding proteins deprives neurons of the capacity to buffer high levels of intracellular Ca(2+) and this leaves them vulnerable to pathological processes, such as those present in Alzheimer's disease (AD). The aim of the present study was to investigate the expression of the calcium binding proteins, calbindin-D28K, calretinin and parvalbumin in the dentate gyrus (DG) of amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic (Tg) mice and their non-Tg littermates, as well as the relation with the deposition of human amyloid beta (Abeta). We measured the expression of these three proteins at seven different rostro-caudal levels, and in the molecular, granular and polymorphic layers of the DG. We found that, except in the most caudal part of the DG, there is a substantial loss of calbindin-D28K immunoreactivity in all three layers of the DG in APP/PS1 mice compared with the non-Tg mice. Significant loss of calretinin immunoreactivity is present in most of the polymorphic layer of the DG of APP/PS1 mice compared with the non-Tg mice, as well as in the rostral and intermediate part of the inner molecular layer. Compared with the non-Tg mice parvalbumin immunoreactivity is significantly reduced throughout the whole polymorphic layer as well as in the rostral and intermediate part of the granular layer of DG in APP/PS1 mice. The relatively preservation of calbindin immunoreactivity in the caudal part of molecular and granular layers as well as calretinin immunoreactivity in the caudal part of polymorphic layer of the DG is likely related to the lower Abeta expression in those parts of DG. The present data suggest an involvement of calcium-dependent pathways in the pathogenesis of AD and indicate that there exists a subfield and layer-specific decrease in immunoreactivity which is related to the type of calcium-binding protein in APP/PS1 mice. Moreover, it seems that APP expression affects more the calbindin expression then parvalbumin and calretinin expression in the DG of APP/PS1 Tg mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583063      PMCID: PMC2596990          DOI: 10.1016/j.neuroscience.2008.05.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  34 in total

1.  Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease.

Authors:  P R Hof; K Cox; W G Young; M R Celio; J Rogers; J H Morrison
Journal:  J Neuropathol Exp Neurol       Date:  1991-07       Impact factor: 3.685

Review 2.  Calcium transport and buffering in neurons.

Authors:  M P Blaustein
Journal:  Trends Neurosci       Date:  1988-10       Impact factor: 13.837

3.  Calretinin/PSA-NCAM immunoreactive granule cells after hippocampal damage produced by kainic acid and DEDTC treatment in mouse.

Authors:  María Isabel Domínguez; José Miguel Blasco-Ibáñez; Carlos Crespo; Ana Isabel Marqués-Marí; Francisco José Martínez-Guijarro
Journal:  Brain Res       Date:  2003-03-21       Impact factor: 3.252

4.  Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.

Authors:  T van Groen; L Liu; S Ikonen; I Kadish
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.

Authors:  Kang-Woo Lee; Si Hyoung Lee; Hyuck Kim; Jin-Sook Song; Sung-Don Yang; Sang Gi Paik; Pyung-Lim Han
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

6.  New storage procedure for human tumor biopsies prior to estrogen receptor measurement.

Authors:  D Crawford; S Cowan; S Hyder; M McMenamin; D Smith; R Leake
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

7.  Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology.

Authors:  Ferenc Mátyás; Tamás F Freund; Attila I Gulyás
Journal:  Hippocampus       Date:  2004       Impact factor: 3.899

8.  A subset of calretinin-positive neurons are abnormal in Alzheimer's disease.

Authors:  J P Brion; A Résibois
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease.

Authors:  P R Hof; E A Nimchinsky; M R Celio; C Bouras; J H Morrison
Journal:  Neurosci Lett       Date:  1993-04-02       Impact factor: 3.046

Review 10.  Neuronal and glial calcium signaling in Alzheimer's disease.

Authors:  Mark P Mattson; Sic L Chan
Journal:  Cell Calcium       Date:  2003 Oct-Nov       Impact factor: 6.817

View more
  13 in total

1.  Hippocampal calbindin-1 immunoreactivity correlate of recognition memory performance in aged mice.

Authors:  Virawudh Soontornniyomkij; Victoria B Risbrough; Jared W Young; Benchawanna Soontornniyomkij; Dilip V Jeste; Cristian L Achim
Journal:  Neurosci Lett       Date:  2012-04-06       Impact factor: 3.046

2.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.

Authors:  Hisaaki Takahashi; Ivona Brasnjevic; Bart P F Rutten; Nicolien Van Der Kolk; Daniel P Perl; Constantin Bouras; Harry W M Steinbusch; Christoph Schmitz; Patrick R Hof; Dara L Dickstein
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

3.  Hypothyroid states mitigate the diabetes-induced reduction of calbindin D-28k, calretinin, and parvalbumin immunoreactivity in type 2 diabetic rats.

Authors:  Sung Min Nam; Yo Na Kim; Dae Young Yoo; Sun Shin Yi; Woosuk Kim; In Koo Hwang; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2011-10-30       Impact factor: 3.996

4.  Neurochemical phenotype of cytoglobin-expressing neurons in the rat hippocampus.

Authors:  Christian Ansgar Hundahl; Jan Fahrenkrug; Jens Hannibal
Journal:  Biomed Rep       Date:  2014-06-16

5.  Aging-related changes in calcium-binding proteins in rat perirhinal cortex.

Authors:  James R Moyer; Sharon C Furtak; John P McGann; Thomas H Brown
Journal:  Neurobiol Aging       Date:  2009-11-04       Impact factor: 4.673

6.  The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease-old wine in new bottles.

Authors:  Karl H Braunewell
Journal:  Front Mol Neurosci       Date:  2012-02-23       Impact factor: 5.639

Review 7.  Calcium in the initiation, progression and as an effector of Alzheimer's disease pathology.

Authors:  Kim N Green
Journal:  J Cell Mol Med       Date:  2009-07-24       Impact factor: 5.310

8.  Modifications of hippocampal circuits and early disruption of adult neurogenesis in the tg2576 mouse model of Alzheimer's disease.

Authors:  Alice Krezymon; Kevin Richetin; Hélène Halley; Laurent Roybon; Jean-Michel Lassalle; Bernard Francès; Laure Verret; Claire Rampon
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  A comparative study of the dentate gyrus in hippocampal sclerosis in epilepsy and dementia.

Authors:  R Bandopadhyay; J Y W Liu; S M Sisodiya; M Thom
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

10.  Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.

Authors:  Jan-Oliver Hollnagel; Shehabeldin Elzoheiry; Karin Gorgas; Stefan Kins; Carlo Antonio Beretta; Joachim Kirsch; Jochen Kuhse; Oliver Kann; Eva Kiss
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.